Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Potential drug discovery for Leishmaniasis


The scientist who identified the target for several drugs used to treat sleeping sickness and Chagas’ disease has just discovered that antimonial drugs used to treat Leishmaniasis attack the same target.

And, he is "highly optimistic" that research on the parasite molecule "trypanothione", and enzymes that use trypanothione, will lead to a drug that will cure all three tropical diseases.

Professor Alan Fairlamb at the University of Dundee has worked out how the sulphur containing compound trypanothione allows these parasites to fend off free radicals and other toxic oxidants produced by the immune system of the infected patient. Antimonial drugs effectively neutralise the leishmania parasite’s antioxidant defence system, allowing the patient to clear the infection. This may explain why so many patients co-infected with HIV fail to respond well to treatment with antimonials.

Alan discovered and named the "trypanothione" compound in 1985. Together with his team they have now worked that trypanothione is vital for parasite survival and now know several enzymes that new drugs will need to target, including one related to a cancer drug target. The drug discovery and development process usually takes between 7 and 12 years but Alan believes it will be more rapid once they move the project into the new Centre for Interdisciplinary Research at the University of Dundee. The new centre, due to open in 2005 with new facilities in high throughput screening and medicinal chemistry will take the drug process further than any other UK university can and to a stage where the pharmaceutical companies will have enough data move it to the production stage.

"Many cases of leishmaniasis in India are now proving resistant to the traditional antimony drugs so new modern drugs are needed soon", explains Professor Fairlamb. "Resistance to antimonials also involves trypanothione" and he plans for his team to also investigate how they can use their discovery to reverse resistance to antimonials until better, safer drugs are developed.

Recent health reports on US soldiers returning home from Iraq with the Leishmaniasis tropical disease has drawn interest to the killer that has 12 million sufferers worldwide. Commonly brought to the attention of Western countries after a war, tropical diseases are not well funded by the pharmaceutical industry as most of their sufferers are in the developing world which is not a profitable market for sales.

Jenny Marra | alfa
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Taming chaos: Calculating probability in complex systems

21.03.2018 | Physics and Astronomy

Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

21.03.2018 | Physics and Astronomy

New 4-D printer could reshape the world we live in

21.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>